Laura M Kreckler Selected Research

2,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylate

12/2006

Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura M Kreckler Research Topics

Disease

2	Inflammation (Inflammations) 09/2011 - 12/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2006 - 03/2004
2	Myocardial Infarction 12/2006 - 03/2004
2	Reperfusion Injury 12/2006 - 03/2004
2	Infarction (Infarctions) 12/2006 - 03/2004
2	Ischemia 12/2006 - 03/2004
1	Hypoxia (Hypoxemia) 12/2009
1	Coronary Occlusion 12/2006
1	Heart Failure 03/2004

Drug/Important Bio-Agent (IBA)

3	Adenosine (Adenocard)FDA LinkGeneric 09/2011 - 12/2006
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2006 - 03/2004
1	ZM 241385 (ZM241385)IBA 12/2006
1	pyridineIBA 12/2006
1	2,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylateIBA 12/2006
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 12/2006
1	Phenol (Carbolic Acid)FDA Link 12/2006
1	Purinergic P1 Receptor AntagonistsIBA 03/2004
1	1,3- dipropyl- 8- (2- (5,6- epoxy)norbornyl)xanthineIBA 03/2004
1	BG 9928IBA 03/2004
1	Barbital (Barbitone)IBA 03/2004
1	DiureticsIBA 03/2004
1	PropionatesIBA 03/2004
1	XanthineIBA 03/2004
1	triphenyltetrazoliumIBA 03/2004